Neurocrine Biosciences, Inc. (NBIX) Amends Corporate Headquarters Lease
10/2/2009 10:00:20 AM
More...
|
Neurocrine Biosciences, Inc. (NBIX) Gets Funding of up to $75 Million
9/16/2009 7:07:46 AM
More...
|
Neurocrine Biosciences, Inc. (NBIX) to Present at the Thomas Weisel Partners Healthcare Conference Live Audio Webcast Wednesday, September 9, 2009
9/3/2009 9:08:36 AM
More...
|
Neurocrine Biosciences, Inc. (NBIX) Reports Second Quarter 2009 Results
7/30/2009 9:56:57 AM
More...
|
Neurocrine Biosciences, Inc. (NBIX) Announces 2nd Quarter 2009 Earnings Results
7/30/2009 9:13:01 AM
More...
|
Neurocrine Biosciences, Inc. (NBIX)'s Elagolix Successful in Six Month Lilac Petal Study; Safety and Efficacy Confirmed in Patients With Endometriosis
7/29/2009 7:25:44 AM
More...
|
Neurocrine Biosciences, Inc. (NBIX) Announces 2nd Quarter 2009 Earnings Results
7/27/2009 9:14:36 AM
More...
|
Neurocrine Biosciences, Inc. (NBIX) Announces Conference Call and Webcast to Present Second Quarter 2009 Financial Results
7/24/2009 8:40:12 AM
More...
|
Neurocrine Biosciences, Inc. (NBIX) Presents Elagolix Data
6/17/2009 8:12:53 AM
More...
|
Neurocrine Biosciences, Inc. (NBIX) to Present at the 8th Annual Needham Life Sciences Conference
6/4/2009 10:55:46 AM
More...
|
|